Akoya Biosciences Inc.

NASDAQ: AKYA · Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM

Akoya Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-47.53M -55.37M -57.97M -60.35M -68M -63.32M -71.4M -76.35M -73.04M -70.64M -69.44M -63.18M -51.25M -42.94M -30.96M -23.62M -22.64M
Depreciation & Amortization
7.4M 7.65M 7.91M 8.66M 8.82M 8.89M 8.69M 8.05M 7.65M 7.15M 6.62M 5.93M 5.37M 4.79M 4.44M 4.17M 3.96M
Stock-Based Compensation
8.99M 9.31M 9.72M 10.72M 10.63M 10.44M 9.99M 9.16M 8.26M 7.43M 6.72M 5.83M 5.33M 4.04M 2.68M 1.58M 419K
Other Working Capital
14.1M 11.08M 9.95M -1.78M -3.86M -1.39M 3M 9.19M 9.01M 6.63M 7.24M 266K -4.1M -1.32M -6.1M -3.52M -1.02M
Other Non-Cash Items
-12.43M 5.65M 5.95M 24.09M 24.71M 7.03M 6.61M 3.41M 462K 367K 835K 689K 655K 2.75M 4.41M 5.01M 6.95M
Deferred Income Tax
-22K 4K 24K -2.21M -19K -56K -69K 2.13M 25K 35K -20K -40K -135K -155K -77K -68K -30K
Change in Working Capital
8.72M 506K -452K -20.22M -16.2M -13.84M -9.14M -136K 1.32M 2.16M 5.94M 206K -9.56M -4.56M -12.86M -7.78M 1.06M
Operating Cash Flow
-30.49M -44.1M -46.67M -51.17M -51.93M -50.87M -55.32M -53.74M -55.32M -53.5M -49.34M -50.57M -49.6M -36.07M -32.36M -20.71M -10.29M
Capital Expenditures
-1.85M -2.46M -2.01M -2.41M -3.66M -3.65M -3.93M -6.88M -7.03M -7.36M -7.86M -5.94M -5.33M -5.09M -4.22M -3.2M -2.81M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 55K 55K 55K 55K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-60.04M -104.29M -87.33M -69.78M -48.01M n/a -23.05M -23.05M -63.83M -63.83M -40.77M -40.77M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
102.7M 82.7M 62M 31M n/a 7M 30M 41.05M 41.05M 34.05M 11.05M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -48.01M -48.01M -48.01M -48.01M 7M 30M 41.05M 281K -6.72M -29.72M -40.77M n/a n/a 10.14M 10.1M 10.06M
Investing Cash Flow
40.81M -24.05M -27.34M -41.19M -51.67M 3.35M 26.07M 34.17M -6.75M -14.08M -37.58M -46.72M -5.33M -5.09M 5.92M 6.9M 7.26M
Debt Repayment
-841K -1.02M 10.55M 10.54M 10.54M 10.57M 10.59M 20.62M 30.61M 30.63M 19.47M 9.54M -400K -322K 7.2M 7.23M 9.77M
Common Stock Repurchased
149K n/a 94K -120K -55K n/a -94K -94K -94K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.44M -1.44M -1.44M -2.63M -1.19M -1.19M -1.19M
Other Financial Acitivies
-1.99M -2.18M -2.2M -2.18M 46.27M 46.26M 45.45M 45.41M -2.23M -1.9M -865K -837K 137.37M 137.36M 135.37M 135.43M -1.63M
Financial Cash Flow
-3.01M -3.21M 8.32M 8.33M 56.79M 56.81M 56.04M 66.04M 28.38M 28.73M 18.61M 8.7M 136.97M 137.03M 142.57M 142.66M 8.14M
Net Cash Flow
7.31M -71.36M -66.06M -84.39M -47.18M 8.92M 26.79M 46.47M -33.69M -38.85M -68.31M -88.58M 82.05M 95.87M 116.14M 128.85M 5.11M
Free Cash Flow
-32.34M -46.56M -48.68M -53.58M -55.59M -54.52M -59.25M -60.63M -62.35M -60.86M -57.2M -56.51M -54.92M -41.16M -36.58M -23.91M -13.1M